Target Price | $12.24 |
Price | $6.58 |
Potential |
86.02%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Champions Oncology, Inc. 2026 .
The average Champions Oncology, Inc. target price is $12.24.
This is
86.02%
register free of charge
$12.60
91.49%
register free of charge
$12.12
84.19%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Champions Oncology, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Champions Oncology, Inc. stock has an average upside potential 2026 of
86.02%
register free of charge
|
Apr '25 |
2026 Estimates |
|
---|---|---|
Revenue Million $ | 56.94 | 61.10 |
13.52% | 7.31% | |
EBITDA Margin | 11.40% | 5.15% |
213.21% | 54.82% | |
Net Margin | 8.25% | 5.06% |
156.87% | 38.70% |
3 Analysts have issued a sales forecast Champions Oncology, Inc. 2026 . The average Champions Oncology, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Champions Oncology, Inc. EBITDA forecast 2026. The average Champions Oncology, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Champions Oncology, Inc. Analysts have issued a net profit forecast 2026. The average Champions Oncology, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Apr '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.33 | 0.22 |
161.11% | 33.33% | |
P/E | 29.32 | |
EV/Sales | 1.32 |
3 Analysts have issued a Champions Oncology, Inc. forecast for earnings per share. The average Champions Oncology, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Champions Oncology, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Craig-Hallum |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Sep 12 2024 |
Analyst Rating | Date |
---|---|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Dec 12 2024 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Sep 12 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.